Phase Ib study of olinvacimab (O) with pembrolizumab (P) in patients with recurrent glioblastoma (rGBM).

Nowak, AK; Cher, L; Bowyer, S; Gan, HK; Long, AP; Balasubramanian, A; Lee, SY; Lee, WS; Yoo, JS

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):